The European Medicines Agency (EMA) has issued its third Letter of Support to the Macustar consortiu...

Harrow, a leading eye care pharmaceutical company in North America, has announced the launch of Harr...

SeaBeLife has announced promising in vivo preclinical results for its investigational drug SBL03, an...

Viralgen and Axovia Therapeutics have announced a strategic collaboration to develop and manufacture...

Apellis Pharmaceuticals has announced that the Therapeutic Goods Administration (TGA) of Australia h...

Norlase, a global leader in ophthalmic laser technology, has announced the commercial launch of LYNX...

MERIT, a global provider of clinical trial endpoint and technology services, has announced the acqui...

Outlook Therapeutics shared results from the NORSE EIGHT clinical trial at the Hawaiian Eye and Reti...

Arctic Vision has received regulatory approval for ARCATUS (triamcinolone acetonide 4 mg/0.1 mL inje...

Stuart Therapeutics has announced the successful completion of its Phase 3 clinical trial for ST-100...